Introduction
Transmission of infectious diseases by the administration of blood, its components or derivatives, has been known since the beginning of transfusion. However, 50 years ago, syphilis was the only disease which was serologically screened. Posttransfusion hepatitis (PTH) occurred in about 30% ofblood recipients in the US, but no laboratory test was available before 1969. During the last 20 years, the striking increase in the use of blood components and derivatives, and advances in the knowledge of diseases transmitted by blood has made this an area of major technological change, particularly where the screening of blood donors is concerned (Table I ). In addition, the fear of developing the acquired immunodeficiency syndrome (AIDS) after transfusion has resulted in transfusion transmitted disease becoming a matter of major public concern, with significant effects on transfusion practice, and the acceptability to the individual patient of treatment with blood and blood products. The 
